Skip to content

Loading your page…

Active substance · L01XL11

Lifileucel

On 3 registers3 medicines2 companies

See every medicineAsk Osler about it

Classification

Anatomical main groupLAntineoplastic and immunomodulating agents
Therapeutic subgroupL01Antineoplastic agents
Pharmacological subgroupL01XOther antineoplastic agents
Chemical substanceL01XL11Lifileucel

Where it is registered

Each register with its number of medicines and a few of them.

Canada
Health Canada · 1 medicine
- Amtagvi72000000000 CELLS / 100 ML · Suspension · Iovance Biotherapeutics, INC.
European Union
EMA · 1 medicine · Historical list
- AmtagviIovance Biotherapeutics B.V.
United States
FDA · 1 medicine
- Amtagvi7.5x10^9 to 72x10^9Cells · Suspension · Iovance Biotherapeutics, Inc.

All medicines with Lifileucel

Every register, a page at a time. Strengths and packs are on each medicine’s page.

1 result

Medicine	Register	Strength	Form	Status	Holder
Amtagvi	European Union			Refused	Iovance Biotherapeutics B.V.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.